• The presence of β-lactamase—producing bacteria in clinical specimens was investigated in 185 children with orofacial or respiratory tract infections. All of these patients failed to respond to antimicrobial therapy, including penicillins, that was administered to 148 (80%) of them. β-Lactamase—producing aerobic and anaerobic bacteria were detected in 75 (40.5%) of the 185 children. The β-lactamase—producing strains included all 11 strains of the Bacteroides fragilis group, 30 (45.4%) of the 66 strains of the Bacteroides melaninogenicus group, five (41.7%) of the 12 strains of Bacteroides oralis, and 41 (97.6%) of 42 strains of Staphylococcus aureus. All β-lactamase—producing Bacteroides strains were resistant to penicillin as compared with the non-β-lactamase—producing strains. Clinical cure was achieved after surgical drainage and a change in antimicrobial therapy in most of the patients. In treatment of orofacial and respiratory tract infections, the clinician should consider the presence of β-lactamase—producing Bacteroides sp and S aureus as a possible cause of clinical failure with various penicillin therapies.
(Arch Otolaryngol 1984;110:228-231)
Brook I. β-Lactamase—Producing Bacteria Recovered After Clinical Failures With Various Penicillin Therapy. Arch Otolaryngol. 1984;110(4):228–231. doi:10.1001/archotol.1984.00800300020004
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: